AK Indication Clause Samples

AK Indication. The following shall apply to the development of a Product in the AK indication (the “AK Product”): 5.4.1 AK Development Proposal. MediGene will submit the final study report relating to the Phase II Clinical Trials with the MediGene internal code number [*] conducted as a proof-of-concept study regarding the AK Product together with a proposed development program for the AK Product (such study report and proposed program being, collectively, the “AK Development Proposal”) to B▇▇▇▇▇▇.